A refractory case of community-acquired pneumonia.
Schlaudecker
Jeffrey D
JD
Inpatient Family Medicine Service, The Christ Hospital/University of Cincinnati Family Medicine Residency, Cincinnati, OH 45219, USA. schlaj@fammed.uc.edu
D000081:Acetamides / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001249:Asthma / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D017714:Community-Acquired Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D016638:Critical Illness; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D004636:Emergency Service, Hospital; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069349:Linezolid; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D008826:Microbial Sensitivity Tests; D023303:Oxazolidinones / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D011023:Pneumonia, Staphylococcal / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D013902:Radiography, Thoracic; D012008:Recurrence; D018570:Risk Assessment; D013183:Sputum / Q000382:microbiology; D013203:Staphylococcal Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D014640:Vancomycin; D000069349:Linezolid